Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats. - Wikidata - wikimedia - TriplyDB

Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats.

Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats.

http://www.wikidata.org/entity/Q36110085

about

mTORC1 Is a Local, Postsynaptic Voltage Sensor Regulated by Positive and Negative Feedback Pathways.Erythropoietin attenuates loss of potassium chloride co-transporters following prenatal brain injury.Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex Impact of rapamycin on status epilepticus induced hippocampal pathology and weight gain.A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials.Neuroinflammation and comorbidity of pain and depression.Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic?mTOR inhibition in epilepsy: rationale and clinical perspectives.How does the ketogenic diet work? Four potential mechanisms Non-invasive treatment options for focal cortical dysplasia.Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.mTOR referees memory and disease through mRNA repression and competition.mTOR as a potential treatment target for epilepsy.M-Calpain Activation Facilitates Seizure Induced KCC2 Down Regulation

P2860

Q33736580-151A2C7E-2323-4729-8F4D-0CFCD925FF05 Q34053756-FB5B7613-5589-4DD4-ABFE-A29D3DBF7778 Q35832641-CD3D87E5-D488-4B94-9426-8CC992185EC3 Q36880550-8B3B4AF6-0CE2-40D9-A501-B3C4CBC61E6B Q37419785-507071C9-8D9E-4A35-92E7-3A66E825778A Q37432089-9F7A635C-F4BF-4830-A71C-EA3D6098E6BF Q38164039-28AF79BD-91E8-46AE-8A59-C0B3595F1C74 Q38336887-D9354DD7-7FB2-40A4-BE9B-EBE9EE5BD520 Q38582924-AE5223A7-0E4B-4167-AB1C-DA6192D8CAFB Q38832204-BE1276D5-1941-445E-AAA2-F6CF51406632 Q39126886-6CF0C2F5-B6C6-4EA2-AD03-4B6F992A685E Q39298436-1F9593A1-E7C2-43ED-8595-4EEBFC3AA522 Q39429483-09DD804F-8850-4E83-AC1F-A56B861A708F Q58729297-9EB10FB7-F4E7-4626-814F-2C9F1F9DB3AC

P2860

Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats.

http://www.wikidata.org/entity/Q36110085

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Rapamycin down-regulates KCC2 ...... convulsants in immature rats.

@ast

Rapamycin down-regulates KCC2 ...... convulsants in immature rats.

@en

type

label

Rapamycin down-regulates KCC2 ...... convulsants in immature rats.

@ast

Rapamycin down-regulates KCC2 ...... convulsants in immature rats.

@en

prefLabel

Rapamycin down-regulates KCC2 ...... convulsants in immature rats.

@ast

Rapamycin down-regulates KCC2 ...... convulsants in immature rats.

@en

P1433

Q36110085-FE3D87BD-E64A-4368-8E6E-D1934637C197

P1476

Q36110085-7D1C0F00-1FCA-44B6-BA66-F61CCA968759

P2093

Q36110085-2F3CD087-3C99-432D-8DF5-5D856D337DE0

Q36110085-43082DF1-BFB3-4454-A155-553E87D099A1

Q36110085-90C47AE7-CBD4-46CE-9CB4-E33A78FC3C09

Q36110085-CAA42F11-5D63-41B3-89D0-CC4F56895FC6

Q36110085-FD77727D-7F37-4871-BC73-EF495EBA6453

P2860

Q36110085-01B39259-E0B8-4CAE-BDCE-1B0CEECF65DF

Q36110085-021B0942-AF1B-4579-ABE1-2391712104C7

Q36110085-142E825A-2B56-4D69-A5CB-D91397A6FCAD

Q36110085-1F34D618-1C51-42A5-9A73-F56C6DD84914

Q36110085-22603680-60C6-423E-8370-DC1532DB859C

Q36110085-252680CE-15E4-4D24-8346-F00EDC28ACA4

Q36110085-2ED45080-9713-4026-9C0D-2E5CB39E7894

Q36110085-2FE3DDF8-4937-4F60-B01B-855AF8DBF3D8

Q36110085-37567B37-76AA-4821-8036-E7A417891F4C

Q36110085-391B2D1B-39EE-4367-AB8B-4867CDDE050C

P304

Q36110085-3629A35C-6C2B-4839-989A-CA48C7CC0690

P31

Q36110085-6A22BA06-B125-4BD6-B0E8-2FA23382172A

P356

Q36110085-07EDEBA5-1520-4B61-A754-17E6FE782FF7

P407

Q36110085-7795A78D-5CD4-4A25-B376-BC610D812ECA

P478

Q36110085-88B0749A-E9AB-4A15-A1FC-D3145C66C5C6

P577

Q36110085-E2AC8ECB-E343-4428-9694-A1F85DA0D4D1

P698

Q36110085-CA1D7453-D9A8-4E10-A110-6630D4096738

P932

Q36110085-3C428113-3AF9-4B71-974A-2A13754E4525

P356

J.NEUROSCIENCE.2012.05.003

P1433

P1476

Rapamycin down-regulates KCC2 ...... convulsants in immature rats.

@en

P2093

D Shin

http://www.w3.org/2001/XMLSchema#string

J McMahon

http://www.w3.org/2001/XMLSchema#string

J Yang

http://www.w3.org/2001/XMLSchema#string

X Huang

http://www.w3.org/2001/XMLSchema#string

Y Huang

http://www.w3.org/2001/XMLSchema#string

P2860

The neuronal K-Cl cotransporter KCC2 influences postsynaptic AMPA receptor content and lateral diffusion in dendritic spines

RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1

NKCC1 transporter facilitates seizures in the developing brain

The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation

Behavioural phenotypes of hypomorphic KCC2-deficient mice

Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition

The cationic amino acid transporters CAT1 and CAT3 mediate NMDA receptor activation-dependent changes in elaboration of neuronal processes via the mammalian target of rapamycin mTOR pathway

Reduction of KCC2 expression and GABAA receptor-mediated excitation after in vivo axonal injury

Functional characterization of the neuronal-specific K-Cl cotransporter: implications for [K+]o regulation

Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2

P304

33-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROSCIENCE.2012.05.003

http://www.w3.org/2001/XMLSchema#string

P407

P478

219

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22613737

http://www.w3.org/2001/XMLSchema#string

P932

3402618

http://www.w3.org/2001/XMLSchema#string